Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -5.98
- Piotroski Score 4.00
- Grade Buy
- Symbol (XOMAP)
- Company XOMA Corporation
- Price $25.69
- Changes Percentage (-0.08%)
- Change -$0.02
- Day Low $25.69
- Day High $25.69
- Year High $26.51
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
- Last Earnings 07/24/2024
- Ex-Dividend for 5/16 Dividend 10/03/2024
- Dividend Payable 10/15/2024
- Today N/A
- Next Earnings (Estimated) 11/07/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $1.00
- Trailing P/E Ratio 24.98
- Forward P/E Ratio 24.98
- P/E Growth 24.98
- Net Income $-40,831,000
Income Statement
Quarterly
Annual
Latest News of XOMAP
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
XOMA Corporation's (NASDAQ:XOMA) institutional investors lost 11% last week but have benefitted from longer-term gains
Analyst forecasts and ownership research offer insights into a stock's potential. Institutional investors hold 35% of XOMA Corporation shares, affecting stock movement. Hedge funds and insiders also p...
By Yahoo! Finance | 4 months ago
